Jérôme Bédier
Vorstandsvorsitzender bei Flash Therapeutics SAS
Profil
Jérôme Bédier is currently the President & Chief Executive Officer at Flash Therapeutics SAS since 2023.
Prior to this, he worked as the Chief Operating Officer at Cell-Easy SAS.
Aktive Positionen von Jérôme Bédier
| Unternehmen | Position | Beginn |
|---|---|---|
Flash Therapeutics SAS
 Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Vorstandsvorsitzender | 06.07.2023 |
Ehemalige bekannte Positionen von Jérôme Bédier
| Unternehmen | Position | Ende |
|---|---|---|
Cell-Easy SAS
 Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Geschäftsführer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Flash Therapeutics SAS
Flash Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Flash Therapeutics SAS provides biotechnology products for medical research. It custom products include lentiviral vectors, non-integrating lentiviral vectors, stable cell line and animal models. The company was founded by Pascale Bouill? in 2005 and is headquartered in Toulouse, France. | Commercial Services |
Cell-Easy SAS
Cell-Easy SAS Miscellaneous Commercial ServicesCommercial Services Cell-Easy SAS operates as a stem cell contract development and manufacturing organization. It offers ready-to-inject adipose-derived allogeneic stem cells for preclinical and clinical drug development projects. The company is headquartered in Toulouse, France. | Commercial Services |
